Abstract: Coenzyme Q (Q), an essential component of eukaryotic cells, is synthesized by several enzymes from the precursor 4-hydroxybenzoic acid. Mutations in six of the Q biosynthesis genes cause diseases that can sometimes be ameliorated by oral Q supplementation. We establish here that Coq6, a predicted flavin-dependent monooxygenase, is involved exclusively in the C5-hydroxylation reaction. In an unusual way, the ferredoxin Yah1 and the ferredoxin reductase Arh1 may be the in vivo source of electrons for Coq6. We also show that hydroxylated analogues of 4-hydroxybenzoic acid, such as vanillic acid or 3,4-dihydroxybenzoic acid, restore Q biosynthesis and respiration in a Saccharomyces cerevisiae coq6 mutant. Our results demonstrate that appropriate analogues of 4-hydroxybenzoic acid can bypass a deficient Q biosynthetic enzyme and might be considered for the treatment of some primary Q deficiencies.
We are very happy that the 4 reviewers commented positively on our manuscript "Coenzyme Q biosynthesis: Coq6 catalyzes the C5-hydroxylation reaction and substrate analogues rescue Coq6 deficiency" by Mohammad Ozeir, Ulrich Mühlenhoff, Holger Webert, Roland Lill, Marc
Fontecave, and Fabien Pierrel. We now submit a revised version of this manuscript "Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation reaction and substrate analogues rescue
Coq6 deficiency" which takes into consideration the points raised by the reviewers.
For reviewer 1 :
1) The title has been revised.
2) We have characterized in our previous publication (Chem. Biol. (2010) , 17: 449-459) the 4-AP and 4-HP intermediates accumulated in Yah1 and Arh1 depleted cells. Because of the limited amount of compounds accumulated by the coq6 mutant strains, we did not repeat the NMR analysis.
However, we provide irrefutable evidences that the compounds accumulated by the coq6 mutant strains are indeed identical to 4-AP and 4-HP which accumulate in Yah1 and Arh1 depleted cells.
First, they have the same retention time and electrochemical properties than 4-AP and 4-HP. Second, we now show in Fig. S1B the UV-vis spectra of both compounds which are identical to the ones we previously published for 4-HP and 4-AP (Fig S2C and S3B ). Third, we now mention in the text the monitoring of the compounds by mass spectrometry. The 518/122 and the 519 /123 transitions are characteristics of the carboxytropylium ions formed upon fragmentation of 4-AP and 4-HP respectively. The undistinguishable HPLC-ECD, UV-vis and mass spectrometry properties of 4-AP/4-HP and of the compounds accumulated by the Coq6-deficient strains prove that these compounds are identical.
3) While a scheme showing the proposed relationship between Yah1, Arh1 and Coq6 may be helpful to readers, we consider at this point that our proposal is still speculative and we do not want to "formalize" it by a scheme which may latter be taken as a fact by readers. We added one sentence in the discussion to further clarify our proposed relationship between Yah1, Arh1 and Coq6.
*Response to Reviewers

4) Our present experiments clearly establish that 4-AP and 4-HP do not transfer electrons in
the respiratory chain since yeast strains accumulating these compounds can not grow on respiratory carbon sources (Fig 3A, B) . In this sense, 4-AP and 4-HP may be considered non-functional.
However, the possible function of these compounds in other established Q-dependent cellular functions like an antioxidant activity or an influence on the mitochondrial permeability pore has not
been addressed yet but is certainly behind the scope of this manuscript. Whether 4-AP and 4-HP may be processed into Q, if the enzymatic deficiency that led to their accumulation is relieved, is not known either. 5) We have described in our previous publication (Chem. Biol. (2010) , 17: 449-459) that endogenously synthesized pABA and 4-HB are limiting for Q biosynthesis. We again demonstrate this in fig. S1A by showing that biosynthesized Q levels are increased when exogenous pABA or 4-HB are added to the culture medium.
6) The figures in the supplemental section are now correctly identified. We chose to keep in the main figures chromatograms from cells grown in pABA and 4-HB because 4-AP and 4-HP respectively are characteristic of an impaired C5-hydroxylation. As pointed in comment 4, 4-HP has a retention time very similar to DMQ whereas no other compound elutes close to 4-AP. In consequence, the accumulation of 4-AP which we can unambiguously identify based on its retention time, is diagnostic of a deficiency in the C5-hydroxylation and corroborates the accumulation of 4-HP (which elutes at a retention time close to that of DMQ) seen with cells grown in the presence of 4-HB.
2) Large variation of the Q/DMQ ratio throughout the growth of S. cerevisiae has been described (Cell Mol Life Sci 2009,66,173-186) . The data previously presented in Fig. S1 showed an equal abundance of Q and DMQ for the WT cells which were harvested in exponential growth. We repeated the experiment and analysed the quinone content of cells harvested in stationary phase. The new chromatograms are displayed in Fig. S1A and are similar to the other chromatograms of WT cells (again harvested in stationary phase) presented in other figures.
3) The coq6/Coq8 strain now presented in Fig S1C accumulates 4-HP and no 4-AP because when no exogenous precursor of Q is supplied in the growth medium (pABA or 4-HB) then endogenous 4-HB seems to be the preferred substrate over pABA. This statement has been included in the manuscript.
4) When both 4-HP and DMQ are formed ( fig 2C, 3A, S3C ), the separation although not optimal is visible. We tried to improve the separation by varying the solvents (ethanol, mixture of isopropanol and acetonitrile) but we could not define conditions to better separate all the compounds analyzed (4-AP, 4-HP, DMQ6, Q6, N-DMQ6 (see comment 6 for reviewer 3)). As discussed in In fig 3A and S3C, 4-HP is formed by the endogenous 4-HB entering the Q pathway whereas DMQ is formed from the incomplete transformation of VA into Q 6 .
5) Some repetitions and references have been deleted.
For reviewer 3 :
1) We changed yeast into S. cerevisiae where appropriate.
2) See comment 1 for reviewer 2.
3) The efficient restoration of Q biosynthesis by vanillic acid in the flx1 mutant (Fig S3D) ,
implicates that only the C5-hydroxylation depends on FAD and therefore excludes that an unknown FAD-dependent protein could be required for another step of Q biosynthesis. Since our present work demonstrates that Coq6 is required for this C5-hydroxylation reaction and because Coq6 has been predicted to be a flavin-dependent monooxygenase, we feel that it is reasonable to assume that the FAD deficiency caused by the deletion of flx1 affects Coq6 activity and that Coq6 is an FADdependent protein. However, we agree with reviewer 3 that we do not have a biochemical proof that Coq6 is FAD-dependent and we took care of not making this statement in the text. In addition, based on the crystal structure of para-hydroxybenzoate hydroxylase (PobA) discussed in Protein Science 1997, 6, 2454-2458, the three conserved residues that we mutated in Coq6 are likely involved in FAD and NADPH binding as now stated in the text (the corresponding references were added). We are working on Coq6 heterologous expression and purification but so far our attempts resulted in obtaining an insoluble protein. In consequence, we are not able to address whether Coq6 is a FADbinding protein but as discussed above, our study highly suggests this by clearly showing that Coq6 is required for the C5-hydroxylation and that the C5-hydroxylation is dependent on FAD.
4)
We now show the requested data in Fig. 2C 5) See comment 2 for reviewer 2.
6) The peak corresponds to 4-aminodemethoxyquinone (N-DMQ) and forms in Yah1-depleted cells only when pABA is added to the growth medium. The incomplete shut-down of Yah1 results in formation of N-DMQ and of some residual Q as seen in Fig. 4B and S4. We are currently working on a collaborative manuscript in which a particular coq mutant accumulates greater amounts of N-DMQ than Yah1-depleted cells. In this future manuscript, the full characterization of N-DMQ will be detailed and its formation in Yah1-depleted cells will be discussed. 7) Our previous study (Chem. Biol. (2010), 17: 449-459 ) demonstrated the essentiality of Arh1 for the C5-hydroxylation reaction. We have modified the discussion to clarify this point.
8) The review by Kawamukai is now cited.
For reviewer 4 :
We corrected our statement and simply discuss the potential advantage of using hydrophilic substrate analogues like vanillic acid instead of Q supplementation in some primary Q deficiencies.
In addition to all these requested modifications, we improved the completeness of the data set Overall, we have modified the text of the manuscript as presented above and Figure 2 , 3, 4, S1
and S3 have also been modified according to reviewers' comments. 
Introduction
Coenzyme Q or ubiquinone (Q) is a redox active lipid present in most organisms and in all tissues of multicellular eukaryotes where it shuttles electrons from complex I and II to complex III of the mitochondrial respiratory chain and acts as an important lipid-soluble antioxidant. Moreover, Q participates in the control of the mitochondrial membrane transition pore and functions with uncoupling proteins in the mitochondrial inner membrane (Bentinger et al., 2010) . Q contains a polyprenyl tail with six isopentenyl units in Saccharomyces cerevisiae (Q 6 ) and ten in human (Q 10 ) (Kawamukai, 2009) (Figure 1 ). In S. cerevisiae, the biosynthesis of Q is accomplished by multiple conserved mitochondrial matrix enzymes (termed Coq1-Coq9) some of which are assembled in a large Q biosynthetic complex associated with the inner membrane . Mutations affecting five genes involved in Q biosynthesis have been described and result in primary Q deficiencies that cause clinically heterogeneous diseases (Quinzii and Hirano, 2010) . Oral Q 10 supplementation of patients yields significant improvement in some cases (Quinzii and Hirano, 2010) . Very recently, mutations in a sixth gene, COQ6, were shown to cause nephrotic syndrome with sensorineural deafness (Heeringa et al., 2011) .
The initial stage of Q biosynthesis involves Coq2. In S. cerevisiae, Coq2 prenylates 4-hydroxybenzoic acid (4-HB) or the newly identified precursor para-aminobenzoic acid (pABA) to yield 3-hexaprenyl-4-hydroxybenzoic acid (HHB) and 3-hexaprenyl-4-aminobenzoic acid (HAB), respectively ( Figure 1 ) (Marbois et al., 2010; Pierrel et al., 2010) .
The C4-amine originating from pABA is subsequently converted into an hydroxyl at an unidentified step of Q 6 biosynthesis ( Figure 1 ). S. cerevisiae cells depleted for either the mitochondrial ferredoxin Yah1 or the mitochondrial ferredoxin reductase Arh1 synthesize almost no Q 6 and accumulate 3-hexaprenyl-4-aminophenol (4-AP) upon culturing in the presence of pABA or 3-hexaprenyl-4-hydroxyphenol (4-HP) in the presence of 4-HB ( Figure   1 ) (Pierrel et al., 2010) . This result established that Yah1 and Arh1 are absolutely required for the C5-hydroxylation step. Arh1 and Yah1 form a well established electron transfer complex necessary in S. cerevisiae for iron sulphur cluster (ISC) and heme A biosynthesis (Barros et al., 2002; Lange et al., 2000; Li et al., 2001 ). Yah1 has two human homologues, Fdx1 and Fdx2. Fdx1 functions in steroid biogenesis by transferring electrons to mitochondrial cytochrome P450 enzymes whereas Fdx2 transfers electrons for the biogenesis of heme A and ISC (Sheftel et al., 2010) .
Coq6 is required for Q 6 biosynthesis in Saccharomyces cerevisiae (Gin et al., 2003) and, based on its amino acid sequence, has been predicted to belong to the class A flavoprotein monooxygenase family suggesting that it contains a FAD cofactor (van Berkel et al., 2006) . Coq6 has been postulated to function in the C1-and/or the C5-hydroxylation reactions (Gin et al., 2003) (Figure 1 ). This ambiguity has not been resolved partly because a S. cerevisiae mutant lacking the entire COQ6 gene (coq6) accumulates only the early Q 6 biosynthetic intermediate, HHB when grown in the presence of 4-HB (Gin et al., 2003) . In fact, the coq3-9 mutants all accumulate HHB because most Coq polypeptides (excluding Coq1, Coq2, Coq5 and Coq8) are interdependent for their stability within the Q biosynthetic complex (Hsieh et al., 2007) . Indeed, the absence of a single Coq polypeptide causes the degradation of other Coq proteins , thus preventing the biosynthesis of Q 6 intermediates diagnostic of the altered step in coq mutants. Consequently, it has been difficult to elucidate the precise function of Coq4, Coq6 and Coq9. Coq8, a predicted protein kinase, is essential for Q 6 biosynthesis and participates in the phosphorylation of Coq3, Coq5
and Coq7 (Tauche et al., 2008; Xie et al., 2011) . Overexpression of Coq8 has been shown to restore the levels of Coq3 and Coq4 in most coq mutants (Zampol et al., 2010) . In addition, overexpression of Coq8 in a coq7 strain causes the accumulation of demethoxyquinone (DMQ 6 ) (Padilla et al., 2009) , the substrate of the C6-hydroxylase, Coq7 (Stenmark et al., 2001 ) ( Figure 1 ). This result implies that overexpression of Coq8 in the coq7 strain prevents the degradation of the Coq polypeptides involved in Q 6 biosynthetic steps upstream of Coq7.
DMQ 6 also forms in a coq7 strain expressing the inactive allele COQ7-E233K even in the absence of Coq8 overexpression (Padilla et al., 2004) . It therefore seems that single mutations in a given Coq protein have less impact on the integrity of the Q 6 biosynthetic complex than null mutations.
In the current study, we sought to define which hydroxylation step of Q 6 biosynthesis is dependent on Coq6. We show that a coq6 strain expressing inactive COQ6 alleles or overexpressing Coq8 accumulates products of the Q 6 biosynthetic pathway which establish that the monooxygenase Coq6 is specifically required for the C5-hydroxylation reaction. The functional combination of Yah1, Arh1 and Coq6 in the C5-hydroxylation reaction is discussed.
In addition, we demonstrate that hydroxylated forms of 4-HB like vanillic acid or 3,4-dihydroxybenzoic acid are able to restore Q 6 biosynthesis and respiration in a S.
cerevisiae strain deficient for Coq6. This represents the first indication that the use of 4-HB analogues might be considered as a strategy to bypass defective steps in the Q biosynthetic pathway.
Results
Coq6 is required for the C5-but not the C1-hydroxylation reaction of Q biosynthesis.
Regular synthetic yeast growth medium contains pABA which is a precursor of Q 6 (Marbois et al., 2010; Pierrel et al., 2010) . In order to control the nature of the precursors employed for Q 6 biosynthesis, we used a synthetic medium without pABA for all our experiments.
Electrochemical detection (ECD) of cell lipid extracts separated by HPLC revealed that addition of pABA or 4-HB to the growth medium increased the Q 6 and DMQ 6 content of S.
cerevisiae ( Figure S1A ) consistent with our previous conclusion that endogenous 4-HB is limiting for Q 6 biosynthesis (Pierrel et al., 2010) . Overexpression of Coq8 in the coq6 mutant strain led to an accumulation of 4-AP or 4-HP in cells cultured in the presence of pABA or 4-HB, respectively, whereas no products were formed in the absence of Coq8 overexpression ( Figure 2A ). Identities of 4-AP and 4-HP were established previously (Pierrel et al., 2010) and here confirmed by their retention time in HPLC chromatograms, their UV-vis spectra ( Figure S1B ) and the expected ion transitions (m/z: 518.3/122 for 4-AP and 519.3/123
for 4-HP) in mass spectrometry coupled to HPLC (data not shown). Without pABA or 4-HB supplementation of the growth medium, the coq6 strain overexpressing Coq8 accumulated 4-HP suggesting that endogenous 4-HB enters the Q biosynthetic pathway preferentially over endogenous pABA ( Figure S1C ). We also mutated residues in Coq6 (G202, G386, N388) selected on the basis of their conservation in other flavoprotein monooxygenases ( Figure S2 ) in which they are implicated in the binding of NADPH and FAD, as shown in the case of the para-hydroxybenzoate hydroxylase PobA (Eppink et al., 1997; Palfey et al., 1994) . As expected, a vector coding for Coq6 restored Q  biosynthesis in the coq6 strain whereas G202A and G386A-N388D mutant alleles of COQ6 were inactive as proven by the absence of Q  and DMQ 6 ( Figure 2B and Figure S1C ). However, these mutants caused an accumulation of 4-AP in coq6 cells cultured in the presence of pABA, and of 4-HP upon growth in the presence of 4-HB ( Figure 2B ). Together, these results show that a coq6 strain either expressing a Coq6 protein inactivated by point mutations or overexpressing Coq8 accumulates 4-AP and 4-HP. This finding demonstrates that the C1-but not the C5-hydroxylation reaction is still catalyzed in the absence of Coq6 activity (Figure 1 ). Since
Coq6 is a predicted FAD-dependent monooxygenase (Gin et al., 2003; van Berkel et al., 2006) , we checked whether the C5-hydroxylation is dependent on the availability of FAD in mitochondria. Deletion of the gene FLX1 which codes for a mitochondrial FAD transporter results in decreased activity of FAD-dependent mitochondrial enzymes (Bafunno et al., 2004; Tzagoloff et al., 1996) . The flx1 strain showed markedly diminished levels of Q 6 and accumulated 4-AP and 4-HP when cultured in the presence of pABA and 4-HB respectively ( Figure 2C ). Furthermore, we observed that overexpression of Fad1, the flavin adenine dinucleotide synthetase, restored Q 6 biosynthesis in the flx1 strain, however without completely abolishing the formation of 4-HP ( Figure 2C ). This result is in agreement with the overexpression of Fad1 being able to partially complement the mitochondrial FAD deficiency of a flx1 mutant strain (Wu et al., 1995) . Collectively, our results show that the C5-hydroxylation depends on mitochondrial FAD and that Coq6, a predicted FAD-dependent monooxygenase, is essential for the C5-but not for the C1-hydroxylation reaction of Q 6 biosynthesis.
Vanillic acid and 3,4-dihydroxybenzoic acid restore Q 6 biosynthesis in strains lacking Coq6 activity.
We tested whether hydroxylated forms of 4-HB like 3,4-dihydroxybenzoic acid (3,4-diHB) or vanillic acid (VA) ( Figure S3A ) may enter the Q 6 biosynthetic pathway and therefore bypass the C5-hydroxylation step which is deficient in coq6 mutants. Addition of 3,4-diHB or VA to the growth medium restored Q 6 biosynthesis in a dose-dependent manner in the coq6 strain overexpressing Coq8 ( Figure 3A and Figure S3B ) or expressing the inactive Coq6 mutant G386A-N388D ( Figure S3C ). The coq6 strain containing only an empty vector synthesized no Q 6 from VA showing that the integrity of the Q biosynthetic complex is required to convert VA in Q 6 ( Figure S3B ). The coq6 strain overexpressing Coq8 or expressing Coq6-G386A-N388D was able to grow on respiratory carbon sources supplemented with 3,4-diHB or VA, showing that Q 6 biosynthesized from these substrate analogues is physiologically functional ( Figure 3B ). When pABA or 4-HB were added in place of VA or 3,4-diHB, the cells were not able to grow on respiratory substrates ( Figure 3B ), thus showing that 4-AP or 4-HP are not competent for electron transfer in the respiratory chain. VA also restored Q 6 biosynthesis in the flx1 mutant to 70% of WT ( Figure S3D ).
Addition of increasing concentrations of 4-HB to the growth medium containing 1mM VA gradually decreased Q 6 levels and promoted the accumulation of 4-HP in the coq6 strain overexpressing Coq8 ( Figure 3C ). pABA had a similar impact on Q 6 levels at concentrations comparable to those of 4-HB ( Figure S3E ). Altogether our data show that exogenous pABA and 4-HB compete with VA to enter the Q 6 biosynthetic pathway at the prenylation step catalyzed by Coq2 and that prenylated VA is converted into Q 6 , therefore bypassing the deficient C5-hydroxylation reaction in coq6 mutant cells.
Coq6 and Yah1 are functionally coupled in the C5-hydroxylation reaction.
Our results show that the phenotypes of cells depleted for Yah1 (Pierrel et al., 2010) or deficient for Coq6 are strikingly similar with regard to Q 6 biosynthesis suggesting a mechanism in which Coq6 and Yah1 work together in the C5-hydroxylation step. The following experiments establish indeed that depletion of Yah1 directly impacts Coq6 activity.
First, we demonstrate that Coq6 is stable when Yah1 is depleted. We constructed a Gal-YAH1
COQ6-3HA strain which contains a chromosomal insertion of a sequence coding for a triple hemagglutinin (3HA) epitope tag on the 3' end of COQ6 and allows for regulated expression of Yah1. Indeed, the native YAH1 promoter has been replaced by the GAL1-10 promoter allowing for expression of Yah1 in a culture medium containing galactose and for depletion of Yah1 in a medium containing glucose (Lange et al., 2000) . The Coq6-3HA protein was detected by immunoblotting at the expected size of 57 kDa ( Figure 4A ). Depletion of Yah1 by culturing the Gal-YAH1 COQ6-3HA strain in the presence of glucose had no effect on the steady-state level of Coq6 ( Figure 4A ). The presence of Coq6 in Yah1-depleted cells is also confirmed by the observation that VA or 3,4-diHB restores Q 6 biosynthesis in the Yah1-depleted cells regardless of Coq8 overexpression ( Figure S4A ), thus showing that the Q biosynthetic complex is intact and therefore that Coq6 is present. Second, overexpression of Fad1 did not complement the Q 6 biosynthetic defect in Yah1-depleted cells ( Figure S4B ), suggesting that this defect does not result from a depletion of mitochondrial FAD. These data together show that Yah1 depletion, while having a negative effect on Q 6 biosynthesis, has no effect on Coq6 stability or mitochondrial FAD content.
Human Fdx2 was recently shown to complement the ISC biosynthetic defect of Yah1-depleted cells (Sheftel et al., 2010) . Surprisingly, none of the two human homologues of Yah1, Fdx1 or Fdx2 complemented the Q 6 defect of Yah1-depleted cells as shown from the observation that the cells contained almost no Q 6 and furthermore accumulated 4-AP upon culture in the presence of pABA ( Figure 4B ). Growth of the Gal-YAH1 strain on synthetic medium containing the respiratory carbon source lactate was limited unless it contained a plasmid carrying the YAH1 gene ( Figure 4C ). With a plasmid expressing Fdx2, growth was restored upon addition of VA or 3,4-diHB to the lactate medium while addition of 4-HB was without any effect ( Figure 4C ). Our results thus suggest that, in the absence of VA or 3,4-diHB, Q 6 is limiting for respiratory growth of the Gal-YAH1 strain expressing Fdx2. This was confirmed by measuring the in vitro activity of succinate dehydrogenase (SDH), a multiprotein complex which contains three ISC and one FAD, all required for activity. As expected from the complementation of the ISC biosynthetic defect of Yah1-depleted cells by Fdx2 (Sheftel et al., 2010) , Fdx2 significantly restored reduction of the chemical dichlorophenolindophenol (DPIP) by SDH in Yah1-depleted cells, although not to WT levels ( Figure 4D ).
Q 6 is required to transfer electrons from SDH to the cytochrome bc 1 complex which reduces cytochrome c (cyt c). Fdx2 restored SDH-cyt c reductase activity in Yah1-depleted cells only when VA was added to the culture medium ( Figure 4D ). This result shows that the limiting factor in transferring electrons from succinate to cyt c in Yah1-depleted cells expressing human Fdx2 is Q 6 , the level of which is restored by addition of VA to the growth medium ( Figure S4A ).
Discussion
Our current work addresses the precise functional role of the Coq6 monooxygenase in the hydroxylation reactions of the Q biosynthetic pathway. As shown previously in the case of the coq7 strain (Padilla et al., 2004; Padilla et al., 2009 ), overexpression of Coq8 or expression of inactive alleles of COQ6 allow for preservation of the integrity of the Q 6 biosynthetic complex in a coq6 strain. We show here for the first time that under these conditions, the coq6 strain grown in the presence of pABA or 4-HB accumulates significant amounts of 4-AP and 4-HP respectively. The accumulation of 4-AP and 4-HP is diagnostic of an impaired C5-hydroxylation but of a functional C1-hydroxylation. As a consequence, the predicted FAD-dependent monooxygenase Coq6 is required for the C5-hydroxylation but not for the C1-hydroxylation, definitively resolving the uncertainty regarding which hydroxylation reaction is catalyzed by Coq6. As a result, the C1-hydroxylase is still unknown ( Figure 5 ) and is unlikely to be any of the Coq proteins identified to date because among these, only Coq6 and Coq7 display sequence homologies with monooxygenases and Coq7 participates exclusively in the C6-hydroxylation (Behan and Lippard, 2010; Padilla et al., 2004) . Some experiments reported here suggest that the C1-hydroxylase is unlikely to be a FAD-dependent monooxygenase. A flx1 strain, characterized by impaired FAD-dependent mitochondrial activities (Bafunno et al., 2004; Tzagoloff et al., 1996) , accumulates 4-AP and 4-HP indicating that the C1-hydroxylase is functional in this mutant ( Figure 2C ).
Furthermore, restoration of Q 6 biosynthesis in flx1 strain by VA ( Figure S3D ) is consistent with the C1-hydroxylation proceeding normally in the flx1 strain.
Our results show that VA and 3,4-diHB can be used as Q 6 precursors and thus restore Q 6 biosynthesis and respiration in coq6 cells overexpressing Coq8 or expressing the Coq6 inactive alleles ( Figure 5 ). This proves that analogues of 4-HB added to the growth medium of S. cerevisiae can reach the mitochondrial matrix, where Q 6 biosynthesis takes place, and then enter the Q 6 biosynthetic pathway via prenylation by Coq2 ( Figure 5 ). The strong impact of minor quantities of pABA or 4-HB observed on the levels of Q 6 synthesized from VA ( Figure 3C and Figure S3E ) may be explained by two non-exclusive hypotheses. VA may not be as efficiently transported to the mitochondrial matrix as pABA and 4-HB or Coq2 may have a higher affinity for pABA and 4-HB compared to VA. In any case, Coq2 has a broad substrate specificity in agreement with early in vitro studies which showed that mitochondrial preparations from rat heart and liver were able to prenylate VA and 3,4-diHB (Nambudiri et al., 1977) . In fact, these analogues of 4-HB meet the structural requirements for prenylation by the polyprenyl transferase Coq2, i.e. an electron-donating substituent at position 4 of the aromatic ring combined with a carboxylic acid, a strong electron-attracting group, at position 1 (Alam et al., 1975) . On the contrary, 4-nitrobenzoic acid which harbours the strong electron-attracting nitro group at position 4 inhibits Coq2 and as a consequence acts as an inhibitor of Q biosynthesis in mammalian cells cultures (Forsman et al., 2010) . We would like to suggest that 4-HB analogues compatible with prenylation by Coq2 may also bypass deficient Q biosynthetic steps downstream of the C5-hydroxylation reaction. It is interesting to note that most mutations identified so far in humans to cause primary Q deficiency are not found in genes encoding enzymes that catalytically modify the prenylated aromatic ring except for COQ6 (Heeringa et al., 2011) . In fact they are found in (i) PDSS1 and PDSS2 mutations. Practically, as vanillin (3-methoxy-4-hydroxybenzaldehyde), a common non-toxic food additive, is converted in the liver to VA (Muskiet and Groen, 1979; Sayavongsaa, 2007) , vanillin may represent an interesting therapeutic molecule to try in patients with COQ6
mutations.
Finally, we previously demonstrated that Yah1 and Arh1 are essential for the C5-hydroxylation reaction (Pierrel et al., 2010) . The similar impact on Q 6 biosynthesis of Yah1 or Arh1 depletion or Coq6 inactivation raises the question of how these three enzymes are functionally coupled. Here we provide preliminary data aiming at understanding this link.
Yah1/Arh1 form a ferredoxin/ferredoxin reductase system that transfers electrons for different mitochondrial processes, in particular ISC assembly (Lill, 2009 strain whereas it failed to do so in Yah1-depleted cells. Third, mitochondrial NAD(P)H levels may not be dramatically affected in Yah1-depleted cells expressing Fdx2 since the latter is able to assemble ISC, a process supported by mitochondrial NADPH (Pain et al., 2010) . Also in support of this, Yah1-depleted cells are prototroph for arginine (data not shown), the biosynthesis of which requires mitochondrial NADPH produced by Pos5 via phosphorylation of mitochondrial NADH (Outten and Culotta, 2003) . As a conclusion, if Coq6 was a classical class A flavoprotein monooxygenase catalyzing reduction of FAD by NAD(P)H, it should be active in Yah1-depleted cells since their levels of mitochondrial FAD and NAD(P)H are not compromised. Consequently, we end up with the hypothesis of an unusual mechanism in which the reducing power of NAD(P)H may transit via the Yah1/Arh1 system before reaching
Coq6. The β-cyclohexenyl carotenoid epoxidase, another class A flavoprotein monooxygenase, has been shown to require a ferredoxin/ferredoxin reductase system for in vitro activity (Bouvier et al., 1996) and thus represents a precedent for such an electron transfer pathway from a ferredoxin to a flavin-monoxygenase. Unequivocal demonstration that Coq6 may also use an unconventional reducing system like Arh1/Yah1 will necessitate the development of an in vitro assay with purified proteins; a challenging task given that Coq6 likely interacts with several Coq polypeptides in the Q 6 biosynthetic complex (Marbois et al., 2005) . Nonetheless, our study has unambiguously established that Coq6 is required exclusively for the C5-hydroxylation of Q 6 biosynthesis and that hydroxylated analogues of 4-HB can be used as precursors of Q 6, two results that significantly improve our understanding of the biosynthesis of this crucial coenzyme.
Significance
Coenzyme Q (Q) or ubiquinone, an important cellular antioxidant, is essential to electron transport chains and is required for several other cellular processes. Q biosynthesis requires at least eleven proteins in S. cerevisiae but the precise function of several of them is not known.
Our work establishes that the predicted monoxygenase Coq6 is involved in the C5-hydroxylation reaction and that an unidentified monooxygenase catalyzes the C1-hydroxylation reaction. We further demonstrate the possibility to bypass a deficient Q biosynthetic step in S. cerevisiae by providing the defective chemical group within a synthetic 4-hydroxybenzoic acid analogue. Indeed, a coq6 mutant impaired in the C5-hydroxylation reaction recovers Q 6 biosynthesis and respiration upon addition of two such analogues, 3,4-dihydroxybenzoic acid and vanillic acid. Primary Q 10 deficiencies have been linked to mutations in six genes of the Q biosynthetic pathway and result in clinically heterogeneous diseases which, if diagnosed early, are improved by Q 10 supplementation. However, the lipophilicity of Q 10 may restrain its efficient transport to the mitochondrial inner membrane where Q 10 functions in the respiratory chain (Quinzii and Hirano, 2010) . Our work suggests that hydrophilic analogues of 4-hydroxybenzoic acid may restore Q 10 biosynthesis in patients with some primary Q 10 deficiencies by bypassing the altered biosynthetic step. The use of various 4-hydroxybenzoic acid analogues will also contribute to characterize the biosynthetic step(s) blocked in some S. cerevisiae coq mutants and will thus help to identify the molecular function of Coq proteins with unknown function. Our work illustrates the importance of a molecular understanding of the Q biosynthetic pathway and warrants the identification of yet unidentified proteins that participates in Q biosynthesis, in particular the monooxygenase responsible for the C1-hydroxylation reaction.
Experimental Procedures
Yeast strains and culture conditions: S. cerevisiae strains used in this study are listed in Table S1 . S. cerevisiae strains were transformed using lithium acetate. A 3HA epitope tag was inserted on the 3' end of COQ6 ORF by PCR as described previously (Longtine et al., 1998) to create the COQ6-3HA strain. This strain was crossed with the Gal-YAH1 strain to isolate the Gal-YAH1 COQ6-3HA strain by selecting the corresponding markers after tetrad dissection. YNB without pABA and folate was from MP Biomedicals. Rich YP medium was prepared as described (Sherman, 2002) . Glucose, galactose or lactate-glycerol were used at 2%. The Gal-YAH1 strain was maintained and precultured on galactose medium. Depletion of Yah1 was accomplished by diluting 200 fold the preculture into glucose containing medium and growing the cells for 18 hours at 30°C.
Plasmids: COQ6 ORF was cloned into pRS416 under the control of the MET25 promoter and the CYC1 terminator using XhoI and XbaI (Mumberg et al., 1994) . This vector served as a template to generate the G202V and G386A-N388D Coq6 mutants by site directed mutagenesis. FAD1 was cloned with its own promoter (370 bp) and terminator (210 bp) into pRS423 using EcoRI and XhoI. Fdx1 and Fdx2 expressing plasmids have been described (Sheftel et al., 2010) and COQ8 cloned in pFL44 was a kind gift from Dr. Geneviève
Dujardin. Sequencing was used to confirm cloning products in all created vectors.
Miscellaneous biochemical analysis:
Isolation of mitochondria and immunostaining were performed as described (Diekert et al., 2001; Harlow and Lane, 1988) . Cellular lipid extraction after addition of the Q 4 standard and quantification of electroactive compounds by HPLC-ECD with a 5011A analytical cell (E1, -420 mV; E2, +380 mV) were as described (Pierrel et al., 2010) . Hydroquinones present in samples were oxidized with a pre-column 5020 guard cell set in oxidizing mode (E, +650 mV). Mitochondrial enzymatic activities were measured as previously described (Pierik et al., 2009 ). cerevisiae. The numbering of the aromatic carbon atoms used throughout this study is shown on HHB and Q 6 . Prenylation of 4-hydroxybenzoic acid (4-HB) or para-aminobenzoic acid (pABA) by Coq2 yields 3-hexaprenyl-4-hydroxybenzoic acid (HHB) or 3-hexaprenyl-4-aminobenzoic acid (HAB). In subsequent reactions, R stands for the hexaprenyl tail and X designates NH 2 or OH. NH 2 is converted into OH prior to demethoxyubiquinone (DMQ 6 ) formation (Marbois et al., 2010; Pierrel et al., 2010) . The three hydroxylation reactions necessary to yield Q 6 are shown in red and the potential implication of Coq6 in the C5-and/or the C1-hydroxylation reactions is indicated (Coq6?). In cells depleted for Yah1 or Arh1, the C5-hydroxylation is deficient which results in synthesis of 3-hexaprenyl-4-aminophenol (4-AP) from HAB and of 3-hexaprenyl-4-hydroxyphenol (4-HP) from HHB (green dashed arrows and green boxes) (Pierrel et al., 2010) . LG 1mM 4-HB 
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Inventory of Supplemental Information
Supplemental information includes four figures and one table. Figure S1 relates to the growth media used in Figure 2 . Figure S2 is a sequence alignment of Coq6 with other flavine-dependent monooxygenases. It illustrates the residues that we mutated in Coq6. These Coq6 mutants are used in Figure 2 .
According to the instructions, Figure S1 and S2 should be grouped together because they both relate to Figure 2 , however since the format of Fig. S1 and S2 is different, I took the liberty not to group the figures. Table S1 contains the yeast strains used in this study.
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LGMADKLFKLYHTNFPPVVALRTFGLNLTNKIGPVKNMIIDTLGGNEK------------479 UbiH IGVTDSLVHLFANRWAPLVVGRNIGLMTMELFTPARDVVAQRTLGWVAR-----------392 PobA SWWMTSVLHRFPDTDAFSQRIQQTELEYYLGSEAGLATIAENYVGLPYEEIE--------394 Kmo VTFSRIRYHEAVQRWHWQKKVINKGLFFLGSLIAISSTYLLIHYMSPRSFLRLRRPWNWI 460 : * . Table S1 : Yeast strains used in this study Alignments were generated with ClustalW2. The proteins are the Coq6 monooxygenase from
Coq6 --------------------------UbiH --------------------------
Saccharomyces cerevisiae (AAB61341), the 2-polyprenyl-6-methoxyphenol 4-hydroxylase from Escherichia coli (UbiH, BAA14326), the P-hydroxybenzoate hydroxylase from
Pseudomonas aeruginosa (PobA, P20586) and the kynurenine 3-monooxygenase from Homo sapiens (Kmo, NP_003670). The conserved residues that we mutated in Coq6 (G202, G386
and N388) are highlighted. The DG motif (D201, G202 in Coq6) has been proposed to bind the pyrophosphate moieties of both FAD and NADPH in PobA (Eppink et al., 1997) whereas the N300 from PobA is in contact with the isoalloxazine ring of the active site FAD (Palfey et al., 1994) . 
